0001829126-21-006116.txt : 20210707 0001829126-21-006116.hdr.sgml : 20210707 20210707165538 ACCESSION NUMBER: 0001829126-21-006116 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210707 DATE AS OF CHANGE: 20210707 EFFECTIVENESS DATE: 20210707 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Inspyr Therapeutics, Inc. CENTRAL INDEX KEY: 0001421204 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-405491 FILM NUMBER: 211077978 BUSINESS ADDRESS: STREET 1: 2629 TOWNSGATE RD, SUITE 215 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 BUSINESS PHONE: (210) 479-8112 MAIL ADDRESS: STREET 1: 2629 TOWNSGATE RD, SUITE 215 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 FORMER COMPANY: FORMER CONFORMED NAME: GENSPERA INC DATE OF NAME CHANGE: 20071213 D 1 primary_doc.xml X0708 D LIVE 0001421204 Inspyr Therapeutics, Inc. 2629 TOWNSGATE RD SUITE 215 WESTLAKE VILLAGE CA CALIFORNIA 91361 (818) 597-7552 DELAWARE GenSpera, Inc. GENSPERA INC Corporation true Scott Ogilvie 2629 Townsgate Road Suite 215 Westlake Village CA CALIFORNIA 91361 Director Claire Thom 2629 Townsgate Road Suite 215 Westlake Village CA CALIFORNIA 91361 Director Pharmaceuticals Decline to Disclose 06b false 2021-06-18 false true true true false 100000 600000 600000 0 Includes (i) $500,000 in cash and (ii) $100,000 in cancellation of debt false 2 0 0 0 false Inspyr Therapeutics, Inc. /s/ Scott Ogilvie Scott Ogilvie Director 2021-07-07